Bioceltix S.A. (WSE:BCX)
Poland · Delayed Price · Currency is PLN 94.00
-2.00 (-2.08%)
Sep 5, 2025, 5:02 PM CET
Bioceltix Market Cap
Bioceltix has a market cap or net worth of 462.90 million as of September 5, 2025. Its market cap has increased by 19.90% in one year.
Market Cap
462.90M
Enterprise Value
430.99M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
94.00
Market Cap Chart
Since November 8, 2021, Bioceltix's market cap has increased from 115.04M to 462.90M, an increase of 302.39%. That is a compound annual growth rate of 43.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 462.90M | 7.31% |
| Dec 30, 2024 | 431.38M | 16.07% |
| Dec 29, 2023 | 371.65M | 179.48% |
| Dec 30, 2022 | 132.98M | -22.49% |
| Dec 30, 2021 | 171.57M | 49.14% |
| Nov 8, 2021 | 115.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 6.80B |
| NEUCA | 3.05B |
| Synektik Spólka Akcyjna | 2.07B |
| Voxel | 1.79B |
| Celon Pharma | 1.20B |
| Ryvu Therapeutics | 631.18M |
| Selvita | 591.05M |
| Centrum Medyczne ENEL-MED | 506.22M |